Strategic Signal

AI Access Company Timelines

Wiley AI Access Timeline

Reviewed Strategic Signal records on Wiley’s AI access relationships, rights, and disclosed economics.

3 reviewed recordsLatest record review Nov 18, 2026By Mike Ye

These selected timelines include reviewed registry records with an exact company name or a source-verified participant label. A product, affiliate, or parent name alone does not establish participation. Coverage reflects Strategic Signal’s research sample. Records are ordered by original announcement date. A record may reflect later amendments or evidence updates.

Mar 3, 2026 · Data-rights qualified

Wiley → OpenEvidence

Wiley scientific and medical journals, books, Cochrane systematic reviews and Clinical Answers licensed into OpenEvidence's cited clinical-answer evidence layer.

Wiley role · Provider / asset owner

  • Provider / asset owner — Wiley, Cochrane content licensed through Wiley
  • AI recipient — OpenEvidence
  • Strategic buyer or operator — OpenEvidence

Recorded status · announced historical backfill. Last reviewed Nov 18, 2026.

Access · retrieval. Training rights · not disclosed.

Disclosed economics · No arrangement-specific consideration established in the inspected announcement. Scope · No data-license value is estimated. Aggregate corporate revenue, financing valuations, settlement payments and catalogue capacity are not treated as this arrangement’s price.

Evidence

View registry record SS-AI-2026-17C0042A →

Jun 17, 2025 · Data-rights qualified

Wiley → Undisclosed third large technology company

Wiley content subject to the third large-technology-company AI licensing project disclosed in fiscal 2025 results; exact titles and corpus size undisclosed.

Wiley role · Provider / asset owner

  • Provider / asset owner — Wiley
  • AI recipient — Undisclosed third large technology company
  • Strategic buyer or operator — Undisclosed third large technology company

Recorded status · announced historical backfill. Last reviewed Nov 18, 2026.

Access · corpus delivery. Training rights · not disclosed.

Disclosed economics · Compensation or a revenue opportunity is stated; no recipient-specific amount is established. Scope · No data-license value is estimated. Aggregate corporate revenue, financing valuations, settlement payments and catalogue capacity are not treated as this arrangement’s price.

Evidence

View registry record SS-AI-2025-C7137F1E →

May 8, 2025 · Governed access

Wiley → Perplexity

Wiley scholarly and educational content integrated into AI search with attribution and sourced citations.

Wiley role · Provider / asset owner

  • Provider / asset owner — Wiley
  • AI recipient — Perplexity

Recorded status · announced. Last reviewed Nov 18, 2026.

Access · retrieval. Training rights · not disclosed.

Disclosed economics · Not disclosed

Evidence

View registry record SS-AI-2026-D9586BB0 →